Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Authors: Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha H. Shah, Ronnie Shapira‐Frommer et al.

Year: 2020

MedicinePembrolizumabInternal medicineResponse Evaluation Criteria in Solid TumorsOncology

2,429
Citations
2020
Published
10
Authors
Read PDFDOI